换一批Pharmacogenetic role of ERCC1 genetic variants in treatment response of platinum-based chemotherapy among advanced non-small cell lung cancer patients.
第一作者：
Dianke,Yu
第一单位：
State Key Laboratory of Molecular Oncology, Department of Etiology and Carcinogenesis, Cancer Institute and Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
作者：
医学主题词
抗肿瘤药(Antineoplastic Agents);癌, 非小细胞肺(Carcinoma, Non-Small-Cell Lung);DNA结合蛋白质类(DNA-Binding Proteins);内切核酸酶类(Endonucleases);遗传异质性(Genetic Heterogeneity);遗传变异(Genetic Variation);人类(Humans);肺肿瘤(Lung Neoplasms);肿瘤分期(Neoplasm Staging);铂(Platinum);多态性, 单核苷酸(Polymorphism, Single Nucleotide);预后(Prognosis);出版倾向性(Publication Bias);治疗结果(Treatment Outcome)
DOI
10.1007/s13277-011-0314-y
PMID
22249976
发布时间
2021-10-21
- 浏览16
Tumour biology
877-84页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
